Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | SCD | O00767 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | TACR2 | P21452 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexadecane SCHEMBL22136 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Tetradecane SCHEMBL10526119 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Decane SCHEMBL3666565 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| SCHEMBL23854647 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Tetradecane SCHEMBL25387874 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Decane SCHEMBL23499900 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Hexadecane SCHEMBL23499901 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Tetradecane SCHEMBL23924271 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Decane SCHEMBL8505762 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| Undecane SCHEMBL20767628 | 0.65 | TSHR (1.00) | TSHRTHRBALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105143456-A | Lipid nanoparticles for transfection and related methods | UNIV BRITISH COLUMBIA | 2015-12-09 | — | — | CN | claimed |
| EP-1000037-A1 | PYRIMIDYL OXYPHENYLACETIC ACID DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2000-05-17 | — | — | EP | claimed |
| WO-1999005122-A1 | PYRIMIDYL OXYPHENYLACETIC ACID DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | claimed |
| CN-105813721-B | Device for dispensing particles in small volumes | 不列颠哥伦比亚大学 | 2019-11-05 | — | — | CN | disclosed |
| CN-108291228-A | C/EBP α SARNA compositions and methods of use | 米纳治疗有限公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-107533076-A | Continuous stream microfluid system | 不列颠哥伦比亚大学 | 2018-01-02 | — | — | CN | disclosed |
| CN-107207413-A | Cationic lipid | 卫材R&D管理有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107075515-A | C/EBP alpha compositions and methods of use | 米纳治疗有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-105143456-A | Lipid nanoparticles for transfection and related methods | UNIV BRITISH COLUMBIA | 2015-12-09 | — | — | CN | disclosed |
| US-20070117720-A1 | Compositions with cyclopropenes | AGROFRESH, INC. | 2007-05-24 | — | — | US | disclosed |
| EP-1787513-A2 | Compositions with cyclopropenes | Rohm and Haas Company (US) | 2007-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117720-A1 | Compositions with cyclopropenes | MYB, OSBP, FAR1 | TSHR 2195/4885THRB 1533/4885SCD 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.